Cite

HARVARD Citation

    Coulson, J. et al. (2022). COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy. Journal of infection. 85 (4), pp. 436-480. [Online]. 
  
Back to record